Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Diabetic Nephropathy | Research

Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease

Authors: Xiaodi Zheng, Yuan Gao, Yuhong Huang, Ruihua Dong, Mengxue Yang, Xuemeng Zhang, Miao Zeng, Rui Zhang, Yueyue Wu, Zhiyan Yu, Jun Liu, Bingbing Zha

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Advanced glycation end products (AGEs) deposited in the lens are correlated with those in the kidneys, indicating a possible value in evaluating diabetic kidney disease (DKD). This study explored the value of noninvasively measuring lens AGEs to diagnose and evaluate the severity of diabetic nephropathy in patients with type 2 diabetes mellitus (T2DM).

Methodology

A total of 134 T2DM patients admitted to the Fifth People's Hospital of Shanghai from March 2020 to May 2021 were selected randomly. Patients were divided into low-, medium-and high-risk groups according to the risk assessment criteria for DKD progression and into DKD and non-DKD (non-DKD) groups according to the Guidelines for the Prevention and Treatment of Diabetic Nephropathy in China. The concentrations of noninvasive AGEs in the lens in all the groups were retrospectively analyzed.

Results

The concentration of noninvasive lens AGEs in the high-risk patients, according to the 2012 guidelines of the Global Organization for Improving the Prognosis of Kidney Diseases, was significantly higher than that in the remaining groups. Regression analysis suggested the value of lens AGEs in diagnosing DKD and evaluating DKD severity. Cox regression analysis indicated that the noninvasive lens AGE concentration was positive correlated with the course of disease.

Conclusion

The receiver operating characteristic (ROC) curve suggested that using noninvasive lens AGE measurements has clinical value in the diagnosis of DKD (area under the curve 62.4%,95% confidence interval (CI) 52.4%–73.9%, p = 0.014) and in assessing the severity of DKD (area under the curve 83.2%, 95% CI 74.1%–92.3%, P < 0.001). Noninvasive lens AGE testing helps screen T2DM patients for DKD and evaluate the severity of DKD.
Literature
1.
go back to reference Cheng HT, Xu X, Lim PS, Hung KY. Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015. Diabetes Care. 2021;44(1):89–97.CrossRefPubMed Cheng HT, Xu X, Lim PS, Hung KY. Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015. Diabetes Care. 2021;44(1):89–97.CrossRefPubMed
2.
go back to reference Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.CrossRefPubMed Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.CrossRefPubMed
3.
go back to reference Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS. 10th ed. Brussels: International Diabetes Federation;PMID: 35914061; 2021. Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS. 10th ed. Brussels: International Diabetes Federation;PMID: 35914061; 2021.
4.
go back to reference Pan X, Lin X, Huang X. The Burden of Diabetes-Related Chronic Kidney Disease in China From 1990 to 2019. Front Endocrinol. 2022;13:892860.CrossRef Pan X, Lin X, Huang X. The Burden of Diabetes-Related Chronic Kidney Disease in China From 1990 to 2019. Front Endocrinol. 2022;13:892860.CrossRef
5.
go back to reference Microvascular Complications Group. Diabetes Association of Chinese Medical Association. Guidelines for Prevention and Treatment of Diabetic Nephropathy in China (2021 Edition). Chin J Diabetes. 2021;13(8):762–84. Microvascular Complications Group. Diabetes Association of Chinese Medical Association. Guidelines for Prevention and Treatment of Diabetic Nephropathy in China (2021 Edition). Chin J Diabetes. 2021;13(8):762–84.
6.
go back to reference Poggio ED, McClelland RL, Blank KN, Hansen S, Bansal S, Bomback AS, et al. Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications. Clin J Am Soc Nephrol. 2020;15(11):1595–602.CrossRefPubMedPubMedCentral Poggio ED, McClelland RL, Blank KN, Hansen S, Bansal S, Bomback AS, et al. Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications. Clin J Am Soc Nephrol. 2020;15(11):1595–602.CrossRefPubMedPubMedCentral
7.
go back to reference Kairys P, Frese T, Voigt P, Horn J, Girndt M, Mikolajczyk R. Development of the simulation-based German albuminuria screening model (S-GASM) for estimating the cost-effectiveness of albuminuria screening in Germany. PLoS One. 2022;17(1):e0262227.CrossRefPubMedPubMedCentral Kairys P, Frese T, Voigt P, Horn J, Girndt M, Mikolajczyk R. Development of the simulation-based German albuminuria screening model (S-GASM) for estimating the cost-effectiveness of albuminuria screening in Germany. PLoS One. 2022;17(1):e0262227.CrossRefPubMedPubMedCentral
8.
go back to reference Ahmed A, Deepak M, Helbert RB, Christos PA, Zeid JK, Dominic SCR, et al. Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate. World J Methodol. 2017;7(3):73–92.CrossRef Ahmed A, Deepak M, Helbert RB, Christos PA, Zeid JK, Dominic SCR, et al. Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate. World J Methodol. 2017;7(3):73–92.CrossRef
9.
go back to reference Sun CK, Yang YL, Gao L. The important role of m6A methylation in type 2 diabetes and its complications. Int J Endocrinol Metabol. 2021;41(04):368–71. Sun CK, Yang YL, Gao L. The important role of m6A methylation in type 2 diabetes and its complications. Int J Endocrinol Metabol. 2021;41(04):368–71.
10.
go back to reference Liu MH, Shi JH, Qmh W, Lin YQ, Sun ZX. The application value of contrast-enhanced ultrasound in the surgery of renal masses. Nat Med J China. 2017;97(15):1184–6. Liu MH, Shi JH, Qmh W, Lin YQ, Sun ZX. The application value of contrast-enhanced ultrasound in the surgery of renal masses. Nat Med J China. 2017;97(15):1184–6.
11.
go back to reference Sarma D, Barua SK, Rajeev TP, Baruah SJ. Correlation between differential renal function estimation using CT-based functional renal parenchymal volume and 99mTc - DTPA renal scan. Indian J Urol. 2013;28(4):414–7.CrossRef Sarma D, Barua SK, Rajeev TP, Baruah SJ. Correlation between differential renal function estimation using CT-based functional renal parenchymal volume and 99mTc - DTPA renal scan. Indian J Urol. 2013;28(4):414–7.CrossRef
12.
go back to reference Ren Q, Chen D, Liu X, Yang R, Yuan L, Ding M, et al. Derivation and Validation of a Prediction Model of End-Stage Renal Disease in Patients with Type 2 Diabetes Based on a Systematic Review and Meta-analysis. Front Endocrinol. 2022;13:e825950.CrossRef Ren Q, Chen D, Liu X, Yang R, Yuan L, Ding M, et al. Derivation and Validation of a Prediction Model of End-Stage Renal Disease in Patients with Type 2 Diabetes Based on a Systematic Review and Meta-analysis. Front Endocrinol. 2022;13:e825950.CrossRef
13.
go back to reference Prevention CH. Hypertension Alliance (China) Cardiovascular Disease Branch of Chinese Medical Association, Hypertension Professional Committee of Chinese Physicians Association. Guidelines for the prevention and treatment of hypertension in China (2018 revised edition). Chin Cardiovasc J. 2019;24(1):24–56. Prevention CH. Hypertension Alliance (China) Cardiovascular Disease Branch of Chinese Medical Association, Hypertension Professional Committee of Chinese Physicians Association. Guidelines for the prevention and treatment of hypertension in China (2018 revised edition). Chin Cardiovasc J. 2019;24(1):24–56.
14.
go back to reference Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med. 2018;24(1):2545–59.CrossRef Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med. 2018;24(1):2545–59.CrossRef
15.
go back to reference Liu Q, Wang XU, Yan H. Effect of Thioltransferase on Oxidative Stress Induced by High Glucose and Advanced Glycation End Products in Human Lens Epithelial Cells. Int J Ophthalmol. 2020;14(7):965–72.CrossRef Liu Q, Wang XU, Yan H. Effect of Thioltransferase on Oxidative Stress Induced by High Glucose and Advanced Glycation End Products in Human Lens Epithelial Cells. Int J Ophthalmol. 2020;14(7):965–72.CrossRef
16.
go back to reference Yao JS, Liu Y, Sang MM. Clinical application value of advanced glycation end products of lens in diabetic retinopathy. Chin J Diabetesmellitus. 2022;14(07):696–703. Yao JS, Liu Y, Sang MM. Clinical application value of advanced glycation end products of lens in diabetic retinopathy. Chin J Diabetesmellitus. 2022;14(07):696–703.
17.
go back to reference Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884–95.CrossRefPubMed Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018;71(6):884–95.CrossRefPubMed
18.
go back to reference Campion CG, Sanchez-Ferras O, Batchu SN. Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy. Can J Kidney Health Dis. 2017;4:2054358117705371.CrossRefPubMedPubMedCentral Campion CG, Sanchez-Ferras O, Batchu SN. Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy. Can J Kidney Health Dis. 2017;4:2054358117705371.CrossRefPubMedPubMedCentral
19.
go back to reference Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ. Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther. 2011;13(2):165–70.CrossRefPubMed Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ. Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther. 2011;13(2):165–70.CrossRefPubMed
20.
go back to reference Wang ZS, Zhang QR, Zhu PL, Smit AJ. Correlation analysis between the content of advanced glycation end products in lens and the degree of diabetic retinopathy. Chin J Exp Ophthalmol. 2017;35(11):1030–4. Wang ZS, Zhang QR, Zhu PL, Smit AJ. Correlation analysis between the content of advanced glycation end products in lens and the degree of diabetic retinopathy. Chin J Exp Ophthalmol. 2017;35(11):1030–4.
21.
go back to reference Zhang XM, Gao Y, Yang MX, Zheng XD, Zhang R, Wu YY, et al. Exploration of noninvasive detection of advanced glycation end products in the lens to screen for diabetic kidney disease. Front Endocrinol. 2022;13:892070.CrossRef Zhang XM, Gao Y, Yang MX, Zheng XD, Zhang R, Wu YY, et al. Exploration of noninvasive detection of advanced glycation end products in the lens to screen for diabetic kidney disease. Front Endocrinol. 2022;13:892070.CrossRef
22.
go back to reference Perrone A, Giovino A, Benny J, Martinelli F. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. Oxid Med Cell Longev. 2020;202:3818196. Perrone A, Giovino A, Benny J, Martinelli F. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. Oxid Med Cell Longev. 2020;202:3818196.
23.
go back to reference Prasad K, Dhar I, Zhou Q, Elmoselhi H, Shoker M, Shoker A. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease. Mol Cell Biochem. 2016;423(1–2):1–10. Prasad K, Dhar I, Zhou Q, Elmoselhi H, Shoker M, Shoker A. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease. Mol Cell Biochem. 2016;423(1–2):1–10.
24.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.CrossRefPubMed Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44.CrossRefPubMed
25.
go back to reference Kidney Disease: Improving Global Outcomes(KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;Suppl:1-150. Kidney Disease: Improving Global Outcomes(KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;Suppl:1-150.
26.
go back to reference Rezaei M, Rabizadeh S, Mirahmad M, Hajmiri MS, Nakhjavani M, Hemmatabadi M, et al. The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2022;14:122.CrossRefPubMedPubMedCentral Rezaei M, Rabizadeh S, Mirahmad M, Hajmiri MS, Nakhjavani M, Hemmatabadi M, et al. The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2022;14:122.CrossRefPubMedPubMedCentral
27.
go back to reference Alin S. Measurement of Lens Autofluorescence for Diabetes Screening. J Diabetes Sci Technol. 2014;8:50.CrossRef Alin S. Measurement of Lens Autofluorescence for Diabetes Screening. J Diabetes Sci Technol. 2014;8:50.CrossRef
28.
go back to reference Indyk D, Agnieszka BS, Gamian A, Kuzan A. Advanced glycation end products and their receptors in serum of patients with type 2 diabetes. Sci Rep. 2021;11(1):13264.CrossRefPubMedPubMedCentral Indyk D, Agnieszka BS, Gamian A, Kuzan A. Advanced glycation end products and their receptors in serum of patients with type 2 diabetes. Sci Rep. 2021;11(1):13264.CrossRefPubMedPubMedCentral
29.
go back to reference Takeuchi M, Yamagishi S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Med Hypotheses. 2004;63(3):449–52.CrossRefPubMed Takeuchi M, Yamagishi S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Med Hypotheses. 2004;63(3):449–52.CrossRefPubMed
30.
go back to reference An X, Mao HP, Wei X, Chen JH, Yang X, Li ZB, et al. Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients. Int Urol Nephrol. 2012;44(5):1521–8.CrossRefPubMed An X, Mao HP, Wei X, Chen JH, Yang X, Li ZB, et al. Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients. Int Urol Nephrol. 2012;44(5):1521–8.CrossRefPubMed
31.
go back to reference Kim JH, Lee JH, Lee HS, Shin SJ, Park EJ, Cho ES, et al. Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer. Dove Med Press. 2021;14(1):4457–66. Kim JH, Lee JH, Lee HS, Shin SJ, Park EJ, Cho ES, et al. Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer. Dove Med Press. 2021;14(1):4457–66.
32.
go back to reference Chen C, Cong BL, Wang M, Abdullah M, Wang XL, Zhang YH, et al. Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients. Integr Med Res. 2018;7(2):192–9.CrossRefPubMedPubMedCentral Chen C, Cong BL, Wang M, Abdullah M, Wang XL, Zhang YH, et al. Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients. Integr Med Res. 2018;7(2):192–9.CrossRefPubMedPubMedCentral
Metadata
Title
Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease
Authors
Xiaodi Zheng
Yuan Gao
Yuhong Huang
Ruihua Dong
Mengxue Yang
Xuemeng Zhang
Miao Zeng
Rui Zhang
Yueyue Wu
Zhiyan Yu
Jun Liu
Bingbing Zha
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03428-3

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.